Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of June 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity.
| Metric | Value |
|---|---|
| Date of Purchase | June 04, 2025 |
| Shares Purchased | 815,673 |
| Highest Price Paid | 405.80 pence |
| Lowest Price Paid | 397.10 pence |
| Volume Weighted Average Price | 399.61 pence |
| Registered Share Capital | 9,002,924,933 ordinary shares |
| Treasury Shares Held | 4,080,205 |
| Voting Shares Outstanding | 8,998,844,728 |
Material Changes
Following the settlement of the June 4 transaction, the number of ordinary shares with voting rights decreased to 8,998,844,728. This figure is relevant for shareholders determining notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Outlook, Risks, and Management Commentary
Management confirmed the purchase was made under the existing Buyback Programme. The filing includes a standard disclaimer that the announcement does not constitute an offer or solicitation of securities. No specific guidance, risks, or contingencies regarding future financial performance were disclosed in this document.
Key Facts for Investor Verification
- Verify the total number of shares repurchased to date under the March 28, 2025 programme.
- Confirm the remaining authorization limit for the current buyback programme.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing.
- Monitor the impact of the reduced share count on earnings per share in upcoming financial reports.